IRADIMED CORP (IRMD) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US46266A1097

Price
85.74 USD
Market cap
1.10 bn USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
1.48 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

IRADIMED CORP financials

Fiscal year2025
Revenue83.81 m USD
Gross profit64.32 m USD
Operating income26.15 m USD
EBIT26.35 m USD
Net income22.48 m USD
Diluted EPS – continuing operations1.75 USD

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About IRADIMED CORP

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.